|
妊娠合并自身免疫性疾病不良妊娠结局预测模型的构建及验证
|
Abstract:
目的:构建及验证妊娠合并自身免疫性疾病患者发生不良妊娠结局的个体化预测模型。方法:回顾性分析2016年01月至2022年12月入住青岛大学附属医院产科且入院诊断为妊娠合并明确自身免疫性疾病的患者的资料。对患者的临床资料进行应用单因素分析、多因素Logistic回归分析、LASSO筛选患者发生不良妊娠结局的独立危险因素,建立相应的nomogram预测模型。采用测试集评估预测效能,利用ROC曲线、Bootstrop自抽样法对模型进行验证,进一步评估模型的区分能力和校准性。结果:1) 经过单因素、多因素及LASSO回归分析,筛选出预测妊娠合并自身免疫性疾病发生不良妊娠结局的最优预测变量:高血压、其它并发症数量、血红蛋白、N/L比值、D-二聚体。2) 应用上述最优预测变量建立妊娠合并自身免疫性疾病不良妊娠结局的预测模型的性能较好,灵敏度为74.3%,特异度为82.5%,AUC为0.843 (95% CI: 0.789~0.898),验证集模型的灵敏度为51.3%,特异度为93.1%,AUC为0.75 (95% CI: 0.656~0.845)。3) 通过Bootstrop重复自抽样法获得校准曲线,模拟曲线与实际曲线具有较强一致性。结论:本研究构建预测妊娠合并自身免疫性疾病不良妊娠结局的预测模型,可以作为预测妊娠合并自身免疫性疾病结局的较为简单的工具。
Objective: To construct and verify an individualized prediction model for adverse pregnancy outcomes in pregnant patients with autoimmune diseases. Methods: The data of patients admitted to the Department of Obstetrics, Affiliated Hospital of Qingdao University from January 2016 to December 2022 who were diagnosed with pregnancy combined with definite autoimmune diseases were retrospectively analyzed. Using univariate analysis, multivariate Logistic regression analysis and LASSO to screen independent risk factors for adverse pregnancy outcomes, a nomogram prediction model was established. Test set was used to evaluate the prediction efficiency, ROC curve and Bootstrop self-sampling method were used to verify the model, and the distinguishing ability and calibration of the model were further evaluated. Results: 1) Through univariate, multivariate and LASSO regression analysis, the optimal predictors of adverse pregnancy outcomes with autoimmune diseases were selected: hypertension, number of other complications, hemoglobin, N/L ratio, D-dimer. 2) The application of the above optimal predictors to establish a predictive model for adverse pregnancy outcomes of pregnancy combined with autoimmune diseases has a good performance, with a sensitivity of 74.3%, specificity of 82.5%, and AUC of 0.843 (95% CI: The sensitivity and specificity of the validation set model were 51.3%, 93.1%, and AUC was 0.75 (95% CI: 0.656~0.845). 3) The calibration curve was obtained by Bootstrop repeated self-sampling method, and the simulated curve had a strong consistency with the actual curve. Conclusion: In this study, a prediction model for adverse pregnancy outcomes of pregnancy with autoimmune diseases was established, which can be used as a relatively simple tool to predict the outcome of pregnancy with autoimmune diseases.
[1] | Wahren-Herlenius, M. and D?rner, T. (2013) Immunopathogenic Mechanisms of Systemic Autoimmune Disease. The Lancet, 382, 819-831. https://doi.org/10.1016/s0140-6736(13)60954-x |
[2] | 郭宏霞, 杨孜. 自身免疫性疾病与妊娠[J]. 中国实用妇科与产科杂志, 2014, 30(6): 489-491. |
[3] | Gilbert, W.M., Young, A.L. and Danielsen, B. (2007) Pregnancy Outcomes in Women with Chronic Hypertension: A Population-Based Study. Journal of Reproductive Medicine, 52, 1046-1051. |
[4] | Catov, J.M., Nohr, E.A., Olsen, J. and Ness, R.B. (2008) Chronic Hypertension Related to Risk for Preterm and Term Small for Gestational Age Births. Obstetrics & Gynecology, 112, 290-296. https://doi.org/10.1097/aog.0b013e31817f589b |
[5] | Chatzi, L., Plana, E., Daraki, V., Karakosta, P., Alegkakis, D., Tsatsanis, C., et al. (2009) Metabolic Syndrome in Early Pregnancy and Risk of Preterm Birth. American Journal of Epidemiology, 170, 829-836. https://doi.org/10.1093/aje/kwp211 |
[6] | Petri, M., Howard, D., Repke, J. and Goldman, D.W. (1992) The Hopkins Lupus Pregnancy Center: 1987-1991 Update. American Journal of Reproductive Immunology, 28, 188-191. https://doi.org/10.1111/j.1600-0897.1992.tb00788.x |
[7] | Singer, A.J., Zheng, H., Francis, S., Fermann, G.J., Chang, A.M., Parry, B.A., et al. (2019) D-Dimer Levels in VTE Patients with Distal and Proximal Clots. The American Journal of Emergency Medicine, 37, 33-37. https://doi.org/10.1016/j.ajem.2018.04.040 |
[8] | Na?ez-Terreros, H., Jaime-Perez, J.C., Mu?oz-Espinoza, L.E., Camara-Lemaroy, C.R., Ornelas-Cortinas, G.E., Ramos-Dena, R.D., et al. (2018) D-Dimer from Central and Peripheral Blood Samples in Asymptomatic Central Venous Catheter-Related Thrombosis in Patients with Cancer. Phlebology: The Journal of Venous Disease, 34, 52-57. https://doi.org/10.1177/0268355518772171 |
[9] | 施君, 赵爱民. 风湿免疫性疾病母婴不良结局监测和防范[J]. 中国实用妇科与产科杂志, 2017, 33(3): 267-272. |
[10] | Qin, L., Stanley, S., Ding, H., Zhang, T., Truong, V.T.T., Celhar, T., et al. (2019) Urinary Pro-Thrombotic, Anti-Thrombotic, and Fibrinolytic Molecules as Biomarkers of Lupus Nephritis. Arthritis Research & Therapy, 21, Article No. 176. https://doi.org/10.1186/s13075-019-1959-y |
[11] | Liang, Y., Xie, S., Wu, C., Hu, Y., Zhang, Q., Li, S., et al. (2017) Coagulation Cascade and Complement System in Systemic Lupus Erythematosus. Oncotarget, 9, 14862-14881. https://doi.org/10.18632/oncotarget.23206 |
[12] | Domingueti, C.P., Fóscolo, R.B., Dusse, L.M.S., Reis, J.S., Carvalho, M.d.G., Gomes, K.B., et al. (2018) Association of Different Biomarkers of Renal Function with D-Dimer Levels in Patients with Type 1 Diabetes Mellitus (Renal Biomarkers and D-Dimer in Diabetes). Archives of Endocrinology and Metabolism, 62, 27-33. https://doi.org/10.20945/2359-3997000000003 |
[13] | Tan, L., Wang, Q., Zeng, T., Long, T., Guan, X., Wu, S., et al. (2018) Clinical Significance of Detecting HLA-DR, 14-3-3η Protein and D-Dimer in the Diagnosis of Rheumatoid Arthritis. Biomarkers in Medicine, 12, 697-705. https://doi.org/10.2217/bmm-2017-0371 |
[14] | Gupta, N., Sahu, A., Prabhakar, A., Chatterjee, T., Tyagi, T., Kumari, B., et al. (2017) Activation of NLRP3 Inflammasome Complex Potentiates Venous Thrombosis in Response to Hypoxia. Proceedings of the National Academy of Sciences, 114, 4763-4768. https://doi.org/10.1073/pnas.1620458114 |
[15] | Ruhnau, J., Schulze, J., Dressel, A. and Vogelgesang, A. (2017) Thrombosis, Neuroinflammation, and Poststroke Infection: The Multifaceted Role of Neutrophils in Stroke. Journal of Immunology Research, 2017, Article ID: 5140679. https://doi.org/10.1155/2017/5140679 |
[16] | Wang, L., Wang, C., Jia, X., Yang, M. and Yu, J. (2020) Relationship between Neutrophil-to-Lymphocyte Ratio and Systemic Lupus Erythematosus: A Meta-Analysis. Clinics, 75, e1450. https://doi.org/10.6061/clinics/2020/e1450 |
[17] | Peng, Y., Cao, L., Zeng, Y., Zhang, Z., Chen, D., Zhang, Q., et al. (2015) Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio in Patients with Rheumatoid Arthritis. Open Medicine, 10, 249-253. https://doi.org/10.1515/med-2015-0037 |
[18] | Zeb, A., Khurshid, S., Bano, S., Rasheed, U., Zammurrad, S., Khan, M.S., et al. (2019) The Role of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Markers of Disease Activity in Ankylosing Spondylitis. Cureus, 11, e6025. https://doi.org/10.7759/cureus.6025 |
[19] | Eudy, A.M., Siega-Riz, A.M., Engel, S.M., Franceschini, N., Howard, A.G., Clowse, M.E.B., et al. (2018) Preconceptional Cardiovascular Health and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus. The Journal of Rheumatology, 46, 70-77. https://doi.org/10.3899/jrheum.171066 |
[20] | 宋亦军, 刘俊涛. 自身免疫性疾病是孕期发生还是孕期产科发现[J]. 中国实用妇科与产科杂志, 2022, 38(2): 157-161. |